An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

Sevindik, Omur GokmenOzkurt, Zubeyde NurBoga, CanBesisik, Sevgi KalayogluIpek, YildizGeduk, AyferHarmandali, Aybuke2023-01-122023-01-1220210006-49711528-00200006-49711528-0020https://doi.org/10.1182/blood-2021-150175https://hdl.handle.net/11454/7778363rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 11-14, 2021 -- Atlanta, GA[No Abstract Available]en10.1182/blood-2021-150175info:eu-repo/semantics/openAccessAn Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of TherapyConference Object138WOS:000835740102199Q1